GS
TEVA icon

GTS Securities’s Teva Pharmaceuticals TEVA Stock Holding History

GTS Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-386,300
Closed -$6.96M – 3813
2024
Q3 		$6.96M Sell
386,300
-83,000
-18% -$1.45M 0.02% 689
2024
Q2 		$7.63M Sell
469,300
-245,400
-34% -$3.78M 0.02% 621
2024
Q1 		$10.1M Buy
714,700
+471,900
+194% +$5.95M 0.02% 505
2023
Q4 		$2.53M Buy
242,800
+13,000
+6% +$121K ﹤0.01% 1488
2023
Q3 		$2.34M Buy
+229,800
New +$2.14M ﹤0.01% 1410

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GTS Securities's TEVA Position: Q1 2026 in Review

GTS Securities opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 46,218 shares worth $1.39M. The stake represents 0.05% of the portfolio and ranks #281 among its holdings. This is a return to the name: GTS Securities previously reported a position in TEVA as recently as Q3 2025.

GTS Securities first reported a position in TEVA in Q2 2023 and has held it in 10 quarters since. The position peaked at $14.5M in Q1 2024. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • GTS Securities held 46,218 shares of Teva Pharmaceuticals worth $1.39M as of Q1 2026.
  • Teva Pharmaceuticals was a new GTS Securities position in Q1 2026.
  • Teva Pharmaceuticals made up 0.05% of GTS Securities's portfolio in Q1 2026, its #281 holding.
  • GTS Securities first reported a position in Teva Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
  • GTS Securities's Teva Pharmaceuticals position peaked at $14.5M in Q1 2024.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.